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Abstract
Background: Except for the established risk factors, presence of target organ damage has an important role in the
treatment of hypertensive subjects. The aim of the present study was to estimate the prevalence of target organ
damage in primary care subjects.
Methods: This multi-centre, cross-sectional survey of 115 primary care physicians recruited 1095 consecutive
subjects with hypertension: 611 men (55.8%); and 484 women (44.2%). A detailed history for the presence of
cardiovascular disease and a thorough clinical examination was performed to each subject.
Results: Of the total study population, 44.5% (n = 487) had target organ damage (33.0% had left ventricular
hypertrophy, 21.8% increased carotid intima media thickness, 11.0% elevated plasma creatinine levels and 14.6%
microalbuminuria). Target organ damage was more prevalent in males than in females (P = 0.05). In addition,
males had more often increased carotid intima media thickness than females (P = 0.009). On the contrary, females
had more often microalbuminuria (P = 0.06) than males. No differences were observed between the two genders
regarding left ventricular hypertrophy (P = 0.35) and elevated plasma creatinine levels (P = 0.21). Logistic regression
analysis showed associations between target organ damage and dyslipidemia (P < 0.001), presence of metabolic
syndrome (P = 0.005), diabetes (P < 0.001) and coronary artery disease (P < 0.001).
Conclusion: A significant proportion of hypertensive subjects in primary care had documented associated target
organ damage, with left ventricular hypertrophy being the most prevalent target organ damage.
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Background
Arterial hypertension has been recognized as one of the
major cardiovascular risk factors and management of
hypertensive subjects still remains a challenge for the
clinicians [1]. Except for the established risk factors [age,
gender, family history of cardiovascular disease, smoking,
obesity, dyslipidemia and diabetes mellitus (DM)], pre-
sence of subclinical target organ damage (TOD) (left ven-
tricular hypertrophy, carotid atheromatosis and renal
impairment) has an important role in the treatment of
hypertensive subjects and the prevention of cardiovascu-
lar disease [2,3].
It has been showed that subclinical TOD is a marker of
increased cardiovascular morbidity and mortality [4-9].
Hypertensive subjects with left ventricular hypertrophy
(LVH) [4], increased carotid intima media thickness
(IMT) [5] and microalbuminuria [6-9] show increased
cardiovascular risk. In addition, hypertensive subjects
with apparent macrovascular disease [cerebrovascular
disease, coronary artery disease (CAD) and peripheral
artery disease] have increased cardiovascular risk [9].
Therefore, knowledge of the presence of TOD is of major
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arterial hypertension. However, little data exist regarding
t h ep r e v a l e n c eo fT O Di np r i m a r yc a r es u b j e c t si no u r
country. The aim of the present study was to estimate
the prevalence of TOD in primary care subjects.
Methods
Population
The C.V.P.C. study (Epidemiological Cardio-Vascular
Study in Primary Care) was a multi-center, cross-sectional
survey which was carried out in order to determine the
prevalence of TOD in subjects with hypertension in pri-
mary care. The survey included 1095 subjects with a
known history of hypertension, 611 men (55.8%) and 484
women (44.2%) who consecutively attended 115 Primary
care physicians from 1-10-2009 until 31-10-2009. Only 21
subjects refused to take part in the study. Patient’sm e d i c a l
history recording and physical examination was performed
by the physicians that took part in the study. All data were
documented in patients’ records.
A detailed history for the presence of cardiovascular
disease, TOD, current medication, information about
other diseases and smoking habits was obtained, and a
physical examination was performed. Body weight with
subjects in light clothing without shoes and height was
measured and body mass index (BMI) was calculated.
Waist circumference was measured with a soft tape on
standing, midway between the lowest rib and the iliac
crest. The biochemical parameters were recorded from
laboratory testing in the three months prior to consulta-
tion (or in the days after consultation if no such prior
testing proved available) at local biochemical laboratories.
Blood pressure was measured three consecutive times,
one minute in apart, in the sitting position after 5 minutes
rest period using an appropriate cuff size. All the measure-
ments performed using the A & D UA-705 Upper Arm
Blood Pressure Monitor The mean values of the last 2
measurements was calculated and used in the analysis.
Arterial hypertension was defined according to the current
guidelines [10], when systolic was ≥ 140 mmHg or and/or
diastolic blood pressure was ≥ 90 mmHg or when the
patients were on antihypertensive treatment. In addition
the type of the antihypertensive treatment was recorded.
The controlled hypertension definition was based on sys-
tolic blood pressure ≤ 140 mmHg and diastolic blood
pressure ≤ 85 mmHg in subjects taking antihypertensive
medications.
Dyslipidemia was defined when patients were on statin
treatment. CAD was defined as presence of angina, his-
tory of previous myocardial infarction, positive stress
testing, revascularization procedures or stenosis > 50% at
the coronary arteries. DM was self-reported and defined
as current use of antidiabetic treatment. Renal impair-
ment was defined as plasma creatinine levels ≥ 1.3 mg/dl.
Microalbuminuria was defined as 24 hour urinary albu-
min of 30-300 mg/dl. Presence of LVH and increased
carotid IMT were reported according to subject’s recent
ultrasound examination. Subjects having three or more
of the following criteria (according to the NCEP ATP III
report) [11], were defined as having the metabolic syn-
drome (MS): abdominal obesity (waist circumference
> 102 cm in men and > 88 cm in women), triglycerides
≥ 150 mg/dl, HDL cholesterol: ≤ 40 mg/dl in men and
≤ 50 mg/dl in women, high blood pressure: ≥ 130/
85 mmHg or use of antihypertensive drugs and high
fasting plasma glucose: ≥ 100 mg/dl or treatment for dia-
betes mellitus. Measurement of carotid IMT was per-
formed by carotid ultrasound examination that measured
the thickness of the intimal and medial layers of the
arterial wall (IMT >0.9 mm in the common carotid artery
is a known cardiovascular risk factor) [12]. Retinal exami-
nation was carried out by experienced ophthalmologists
with no prior knowledge of the participants’ blood pres-
sure level.
The study protocol was reviewed by the bioethical
committee of the Hellenic Association of Research and
Continuing Education in Primary Care and a written
consent was obtained from all participants.
Statistical analyses
Data are expressed as mean ± standard deviation (SD).
Student’s t-tests and pearson’s c
2 test was used to com-
pare between-groups differences. Logistic regression
analysis with a backward stepwise approach was
employed to identify variables associated with TOD.
Relative risks (RR) were calculated from logistic regres-
sion models. Any P value ≤ 0.05 (two-tailed) was consid-
ered statistically significant. Data were analyzed using
SPSS v 15.0 (SPSS, Chicago, IL, USA).
Results
The basic demographic characteristics of the study sub-
jects are showed in Table 1. Two hundred eighty one
(25.7%) subjects had a family history of cardiovascular
disease and 28.4% (n = 311) patients had MS. Smokers
were 38.9% of the study population. The most frequent
co-morbidities were DM (25.8%) and dyslipidemia
(59.5%); followed by peripheral artery disease (12.2%),
CAD (11.9%), retinopathy (7.2%), heart failure (7.0%)
and cerebrovascular disease (4.9%).
Blood pressure control
56.8% of the subjects, (n = 622) had blood pressure
levels that were considered well-controlled (< 140/85
mmHg). The above targets for blood pressure were
achieved by 63.1% of the subjects with CAD, 53.5% of
the subjects with TOD and 46.6% of the diabetic sub-
jects. Of the subjects achieved blood pressure levels
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dual anti-hypertensive agents and 27.5% were prescribed
≥3 anti-hypertensive drugs.
Target organ damage
Of the total study population, 44.5% (n = 487) had docu-
mented TOD (33.0% had LVH, 21.8% increased carotid
IMT, 11.0% elevated plasma creatinine levels and 14.6%
microalbuminuria). TOD was more prevalent in males
than in females (49.1% vs. 43.0%, respectively, P = 0.05).
In addition, males had more often increased carotid IMT
than females (25.5% vs. 18.8%, respectively, P = 0.009).
On the contrary, females had more often microalbumi-
nuria (17.5% vs. 13.4%, respectively, P = 0.06) than males.
No differences were observed between the two genders
regarding LVH (34.5% vs. 31.9%, respectively, P = 0.35)
and elevated plasma creatinine levels (10.3% vs. 12.9%,
respectively, P = 0.21) (Table 2).
Of the subjects with dyslipidemia, 53.5% (n = 348) had
documented TOD (41.0% had LVH, 27.5% increased caro-
tid IMT, 14.3% elevated plasma creatinine levels and
18.6% microalbuminuria). Of the subjects with MS, 61.7%
(n = 192) had documented TOD (49.2% had LVH, 29.9%
increased carotid IMT, 21.5% elevated plasma creatinine
levels and 30.9% microalbuminuria). Of the diabetic sub-
jects, 62.2% (n = 176) had documented TOD (45.9% had
LVH, 33.2% increased carotid IMT, 27.2% elevated plasma
creatinine levels and 36.0% microalbuminuria).
Logistic regression analysis showed associations
between TOD and dyslipidemia [odds ratio (OR): 2.04,
95% Confidence Intervals (95% CI): 1.52-2.73, P < 0.001],
presence of MS (OR = 1.64, 95% CI: 1.16-2.31, P =
0.005), DM (OR = 1.93, 95% CI: 1.36-2.7, P < 0.001) and
CAD (OR = 4.06, 95% CI: 2.44-6.76, P < 0.001).
Discussion
In the present study we showed that a significant propor-
tion of hypertensive subjects in primary care had docu-
mented associated TOD. LVH was the most prevalent
TOD followed by increased carotid IMT and renal
impairment. In addition, TOD was more prevalent in
hypertensive males than in females. Studies from differ-
ent populations have demonstrated a high percentage of
TOD among hypertensive subjects [13-19]. Studies from
the U.S.A. [13], Africa [14-17] and Europe [18,19] have
showed high prevalence of TOD in hypertensive subjects.
In addition, in African hypertensive subjects, males had
higher odds of developing TOD compared to females
[14]. It is well established that presense, even subclinical,
of TOD is associated with increased cardiovascular mor-
tality [4-9]. In addition, hypertensive subjects with LVH
[4], increased IMT [5] and microalbuminuria [6-9] show
increased cardiovascular risk. Therefore, presence of
TOD has an important role in the treatment of hyperten-
sive subjects and the prevention of cardiovascular disease
[2,3]. Knowledge of prevalence of TOD in primary care
Table 1 Characteristics of the studied population [data are showed as Mean ± SD or n (%)]
Men Women All P*
Mean age (years) 61.7 ± 10.1 62.1 ± 10.8 61.9 ± 10.5 0.46
Systolic blood pressure (mmHg) 137.3 ± 18.6 134.2 ± 14.7 138.7 ± 17.4 0.54
Diastolic blood pressure (mmHg) 84.5 ± 11.2 80.6 ± 8.7 83.3 ± 10.3 0.62
Body mass index (kg/m
2) 29.0 ± 8.2 28.8 ± 13.2 28.9 ± 10.6 0.71
Waist circumference (cm) 104.3 ± 10.3 102.5 ± 10.0 104.0 ± 10.2 0.49
Smoking status 305 (50.6) 121 (25.6) 426 (38.9) < 0.001
Diabetes mellitus 160 (26.6) 123 (26.0) 283 (25.8) 0.81
Metabolic syndrome 174 (29.1) 137 (29.2) 311 (28.4) 0.96
Heart failure 40 (6.6) 37 (7.8) 77 (7.0) 0.46
Coronary artery disease 102 (16.9) 28 (5.9) 130 (11.9) < 0.001
Dyslipidemia 366 (60.4) 285 (59.6) 651 (59.5) 0.97
Stroke 29 (4.8) 25 (5.2) 54 (4.9) 0.06
Peripheral artery disease 76 (12.6) 58 (12.3) 134 (12.2) 0.89
P-values refer to the comparisons between two genders.
Table 2 Prevalence of target organ damage among hypertensive subjects attending primary care
Target organ damage Men Women All P*
Left ventricular hypertrophy 207 (34.5) 154 (31.9) 361 (33.0) 0.35
Increased carotid intima media thickness 152 (25.5) 87 (18.8) 239 (21.8) 0.009
Elevated plasma creatinine levels 61 (10.3) 59 (12.9) 120 (11.0) 0.22
Microalbuminuria 79 (13.4) 81 (17.5) 160 (14.6) 0.06
P-values refer to the comparisons between two genders.
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subjects at high cardiovascular risk.
It is known that TOD already exists in newly diagnosed
hypertensive subjects [20]. A recent study in our country
showed that subjects with white coat and masked hyper-
tension had TOD in terms of LVH and increased carotid
IMT [21]. It is noteworthy, that even at early stages of
hypertension TOD is present resulting at increased cardi-
ovascular risk among hypertensive subjects [20,21]. Con-
firming previous studies, we showed that LVH was the
most prevalent TOD in hypertensive subjects [13,15-17]
followed by renal impairment [13,19].
Logistic regression analysis showed associations
between TOD and presence of MS, dyslipidemia, DM
and CAD. In hypertensive subjects MS, as a clustering of
cardiovascular risk factors, amplifies TOD [22-24]. A
recent study showed that the risk of LVH, carotid
abnormalities and microalbuminuria increased by the
presence of MS even after adjusting for several confoun-
ders [22]. Another study found a strong association
between MS and TOD by showing that a clustering of
two or three markers of TOD is the prevalent cardiovas-
cular phenotype in MS hypertensive subjects [24]. A
study in this elderly non-diabetic hypertensive subjects
showed that the presence of MS was independently
related to a greater prevalence of TOD and established
cardiovascular disease [24].
In addition, DM and CAD per se have been associated
with TOD in hypertensive subjects [16,19]. TOD tends to
be more prevalent in hypertensi v ed i a b e t i cp a t i e n t st h a n
in non-diabetics [25], as is the case in subjects with MS
[26]. Another study found a relationship between TOD
and established cardiovascular disease [19]. In fact, the
prevalence of established cardiovascular disease was
twice as great in hypertensive subjects with LVH and
renal impairment [19]. Finally, despite previous findings,
i nt h ep r e s e n ts t u d yw ef a i l e dt od e m o n s t r a t ea n ya s s o -
ciation between TOD and blood pressure levels [14,15].
Limitations
The present study has its limitations. In the present study
only subjects with a known history of arterial hyperten-
sion where included and therefore a selection bias could
not be avoided. In addition, information regarding the
duration of antihypertensive treatment and diabetes are
missing. Another limitation is that measurements were
obtained by biochemical laboratories at different regions
and not a central one.
Conclusion
In conclusion, a significant proportion of hypertensive
subjects in primary care had documented associated TOD,
with LVH being the most prevalent TOD. The above find-
ing emphasizes the important role of the primary care
clinicians to the early detection, treatment and control of
high blood pressure that might help to reducing overall
cardiovascular risk.
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